Bourke, Caitlin
Takashima, Eizo
Chan, Li-Jin
Dietrich, Melanie H.
Mazhari, Ramin
White, Michael
Sattabongkot, Jetsumon
Tham, Wai-Hong
Tsuboi, Takafumi
Mueller, Ivo
Longley, Rhea http://orcid.org/0000-0002-4510-5602
Funding for this research was provided by:
National Health and Medical Research Council (1092789, 1134989, 1043345, 1143187, 1173210)
National Institute of Allergy and Infectious Diseases (5R01 AI 104822)
Global Health Innovative Technology Fund (T2015-142)
Howard Hughes Medical Institute-Wellcome International Research Scholar (208693/Z/17/Z)
Article History
Received: 16 November 2021
Accepted: 13 February 2022
First Online: 4 March 2022
Declarations
:
: The Ethics Committee of Faculty of Tropical Medicine, Mahidol University, Thailand approved the twelve-month observational cohort (MUTM 2013-027-01) and nine-month clinical cohort (MUTM 2014-025-01 and 02). The Human Research Ethics Committee, Walter and Eliza Hall Institute of Medical Research, Australia approved the use of collected samples in Melbourne (14/02), and approved collection and/or use of the negative control samples (14/02).
: Not applicable.
: RJL, MW, TT and IM are inventors on patent PCT/US17/67926 on a system, method, apparatus and diagnostic test for <i>Plasmodium vivax.</i>